A follicle-stimulating hormone receptor-targeted near-infrared fluorescent probe for tumor-selective imaging and photothermal therapy

Liu, Qiyu; Pu, Tao; Zhou, Xiaobo; Sun, Jiaan; Yuan, Wei; Zhang, Sidi; Zhang, Mingxing; Zhang, Meng; Peng, Jing; Li, Fuyou; Zhang, Xiaoyan; Xu, Congjian

doi:10.1016/j.mtbio.2023.100904

Cited by 2 publications

(1 citation statement)

References 51 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For example, exosomal and liposomal nano-carriers for mangiferin and curcumin exhibited increased cellular uptake and controlled release (Alharbi et al, 2024). Nanocarriers have also been used to specifically target to tumors, such as the tumor-targeted probes for Follicle-stimulating hormone (Liu et al, 2024). Furthermore, multifunctional nanoparticles (DDP-Ola@HR) which were loaded with both DDP and Olaparib and modified with heparin, have shown effectiveness in inhibiting the growth and metastasis of DDP-resistant OC (Liang et al, 2023).…”

Section: Discussionmentioning

confidence: 99%

Current trends and emerging patterns in the application of nanomaterials for ovarian cancer research: a bibliometric analysis

Wang,

Wei,

Feng

et al. 2024

Front. Pharmacol.

View full text Add to dashboard Cite

Introduction: Ovarian cancer remains to be a significant cause of global cancer-related mortality. In recent years, there has been a surge of studies in investigating the application of nanomaterials in the diagnosis and treatment of ovarian cancer. This study aims to conduct a comprehensive bibliometric analysis regarding nanomaterial-based researches on ovarian cancer to evaluate the current state and emerging patterns in this field.Methods: A thorough literature search on the Web of Science Core Collection database was conducted to identify articles focused on nanomaterial-based ovarian cancer researches. The studies that met the inclusion criteria were selected for further analysis. VOSviewer and CiteSpace were applied for the bibliometric and visual analyses of the selected publications.Results: A total of 2,426 studies were included in this study. The number of annual publications showed a consistent upward trend from 2003 to 2023. Notably, China, the United States, and India have emerged as the leading contributors in this field, accounting for 37.39%, 34.04%, and 5.69% of the publications, respectively. The Chinese Academy of Sciences and Anil K. Sood were identified as the most influential institution and author, respectively. Furthermore, the International Journal of Nanomedicine was the most frequently cited journal. In terms of the research focus, significant attention has been directed towards nanomaterial-related drug delivery, while the exploration of immunogenic cell death and metal-organic frameworks represented recent areas of interest.Conclusion: Through comprehensive analyses, an overview of current research trends and emerging areas of interest regarding the application of nanomaterials in ovarian cancer was illustrated. These findings offered valuable insights into the status and future directions of this dynamic field.

show abstract

Section: Discussionmentioning

confidence: 99%

Current trends and emerging patterns in the application of nanomaterials for ovarian cancer research: a bibliometric analysis

Wang,

Wei,

Feng

et al. 2024

Front. Pharmacol.

View full text Add to dashboard Cite

show abstract

Reactive Oxygen Species‐Triggered Carbon Dots‐Based Biomimetic Nanotheranostic Agents for Atherosclerosis Management

Duan,

Yang,

Mou

et al. 2024

Adv Funct Materials

View full text Add to dashboard Cite

Atherosclerosis (AS) is a chronic inflammation vascular disease, with its ongoing progression can lead to the onset of cardiovascular diseases. Traditional drug therapy is limited by poor drug delivery, insufficient drug accumulation, and notable toxic side effects. In addition, the failure to receive an early AS diagnosis is primarily responsible for the delayed treatment, which subsequently contributes to the high frequency of life‐threatening cardiovascular events. In this work, a macrophage membranes (MM)‐camouflaged reactive oxygen species (ROS)‐sensitive nanotheranostic platform (LC‐MM) is constructed to improve AS target diagnosis and treatment efficacy. Thanks to the strong antioxidant properties of carbon dots (CDs), CDs as drug carriers for lovastatin aimed to synergistically treat AS by reducing ROS accumulation and suppressing inflammatory responses in vitro and in vivo are employed. The active functions of MM coupled with the ROS‐responsiveness of LC nanoplatform are expected to enhance the efficacy of nanotherapy, particularly to reduce lipid deposition, macrophage infiltration, necrotic core size, collagen content, pro‐inflammatory cytokines, and oxidative stress accumulation. Moreover, the near‐infrared emission properties inherited from CDs facilitated precise fluorescence (FL) imaging for AS plaques. Thus, the biomimetic nanotheranostic agent LC‐MM represented a powerful platform for safe and effective AS management.

show abstract

A follicle-stimulating hormone receptor-targeted near-infrared fluorescent probe for tumor-selective imaging and photothermal therapy

Cited by 2 publications

References 51 publications

Current trends and emerging patterns in the application of nanomaterials for ovarian cancer research: a bibliometric analysis

Current trends and emerging patterns in the application of nanomaterials for ovarian cancer research: a bibliometric analysis

Reactive Oxygen Species‐Triggered Carbon Dots‐Based Biomimetic Nanotheranostic Agents for Atherosclerosis Management

Contact Info

Product

Resources

About